High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates pushed to Dec 2027v27
  2. Study title expanded, about 4 wordsv26
  3. 2 versions Re-verified since Oct 22, 2021, no change to tracked fieldsv24-v25
  4. Primary completion date: Dec 2021 to Dec 2025
    • Start date: Jan 1989 to Aug 1989
    v23
  5. Primary completion date: Dec 2020 to Dec 2021
    • Study completion date: Dec 2020 to Dec 2026
    v22
Show 20 earlier versionsHide 20 earlier versions
  1. 8 versions Re-verified since Jan 8, 2014, no change to tracked fieldsv14-v21
  2. Primary and study completion dates: Dec 2020v13
  3. Lead sponsor: University of Kansas to Carol Fabian, MDv12
  4. Re-verified, no change to tracked fieldsv11
  5. Study Status, Arms and Interventionsv10
  6. Re-verified, no change to tracked fieldsv9
  7. Site contact updatedv8
  8. Re-verified, no change to tracked fieldsv7
  9. Study description revisedv6
  10. Enrollment target: 2000 to 3000
    • Eligibility criteria revised
    • Study description expanded, about 5 words
    • Collaborators shortened, about 5 words
    v5
  11. Re-verified, no change to tracked fieldsv4
  12. Enrollment target: 500 to 2000
    • Site contact updated
    v3
  13. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The overall goal of this project is to develop an integrative system of breast cancer risk assessment based on epidemiologic and biologic risk variables, as well as to develop or refine risk biomarkers which may be useful in predicting and monitoring response to prevention interventions.
Trial Details
NCT Number NCT00291096
Lead Sponsor Carol Fabian, MD
Conditions
(from sponsor)		 Breast Cancer
Related terms Breast Neoplasms
Enrollment 3,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov